Georgia's Online Cancer Information Center

Find A Doctor

Georgia Cancer Specialists - CenterPointe
www.gacancer.com

Rodolfo E. Bordoni MD

Specialty
Medical Oncology / Board Certified
Trial Cancers
Bile Duct Cancer, Bladder Cancer, Bone Tumor, Brain & Spinal Cord Tumor, Breast Cancer, Cancer-Related Syndrome, Cervical Cancer, Colon/Rectal Cancer, Esophogeal Cancer, Gynecologic Cancers, Head and Neck Cancer, Hematopoietic Malignancies, Kidney Cancer, Leukemia, Liver Cancer / Hepatoblastoma, Lung Cancer, Lymphoma, Melanoma, Multiple Myeloma, Myelodysplastic Syndromes (MDS), Ovarian Cancer, Pancreatic Cancer, Plasma cell neoplasm, Primary Peritoneal Cancer, Prostate Cancer , Skin Cancer (Non-Melanoma), Stomach/ Gastric Cancer, Thyroid Cancer, Uterine Cancer
Affiliations
Northside Hospital
WellStar Kennestone Hospital

Active Clinical Trial Sites in Georgia

Georgia Cancer Specialists - CenterPointe

1100 Johnson Ferry Road
Suite 600
Sandy Springs, GA 30342
404-256-4777 (p)
www.gacancer.com

driving directions

Clinical Trials
A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies
Cancer Type: Bile Duct Cancer

Targeted Therapy Directed by Genetic Testing in Treating Patients with Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Cancer Type: Bladder Cancer

A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies
Cancer Type: Bladder Cancer

A Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib (LY2835219) in Participants With Prostate Cancer
Cancer Type: Bone Tumor

Targeted Therapy Directed by Genetic Testing in Treating Patients with Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Cancer Type: Brain & Spinal Cord Tumor

DSC-MRI in Measuring Relative Cerebral Blood Volume for Early Response to Bevacizumab in Patients with Recurrent Glioblastoma
Cancer Type: Brain & Spinal Cord Tumor

Observation or Radiation Therapy in Treating Patients with Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery
Cancer Type: Brain & Spinal Cord Tumor

Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel with or without Carboplatin in Treating Patients with Triple-Negative Breast Cancer
Cancer Type: Breast Cancer

Targeted Therapy Directed by Genetic Testing in Treating Patients with Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Cancer Type: Breast Cancer

Testing the Addition of a Blood Pressure Medication, Carvedilol, to HER-2 Targeted Therapy for Metastatic Breast Cancer to Prevent Cardiac Toxicity
Cancer Type: Breast Cancer

A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies
Cancer Type: Breast Cancer

Testing the Drug Atezolizumab or Placebo with Usual Therapy in First-Line HER2-Positive Metastatic Breast Cancer
Cancer Type: Breast Cancer

Tissue Collection and Natural History Study of Patients with Myelodysplastic Syndrome or Myeloproliferative Neoplasms
Cancer Type: Cancer-Related Syndrome

Targeted Therapy Directed by Genetic Testing in Treating Patients with Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Cancer Type: Cervical Cancer

Targeted Therapy Directed by Genetic Testing in Treating Patients with Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Cancer Type: Colon/Rectal Cancer

A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies
Cancer Type: Colon/Rectal Cancer

Targeted Therapy Directed by Genetic Testing in Treating Patients with Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Cancer Type: Esophogeal Cancer

A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies
Cancer Type: Esophogeal Cancer

A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies
Cancer Type: Gynecologic Cancers

Targeted Therapy Directed by Genetic Testing in Treating Patients with Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Cancer Type: Head and Neck Cancer

A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies
Cancer Type: Head and Neck Cancer

A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies
Cancer Type: Hematopoietic Malignancies

Targeted Therapy Directed by Genetic Testing in Treating Patients with Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Cancer Type: Kidney Cancer

Tissue Collection and Natural History Study of Patients with Myelodysplastic Syndrome or Myeloproliferative Neoplasms
Cancer Type: Leukemia

Targeted Therapy Directed by Genetic Testing in Treating Patients with Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Cancer Type: Liver Cancer / Hepatoblastoma

A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies
Cancer Type: Liver Cancer / Hepatoblastoma

Genetic Testing in Screening Patients with Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
Cancer Type: Lung Cancer

Crizotinib in Treating Patients with Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Cancer Type: Lung Cancer

Targeted Therapy Directed by Genetic Testing in Treating Patients with Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Cancer Type: Lung Cancer

Testing Whether Avoiding the Hippocampus During Whole-Brain Radiation Therapy Prevents Cognitive Side Effects in Patients with Small Cell Lung Cancer
Cancer Type: Lung Cancer

A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies
Cancer Type: Lung Cancer

Biomarker-Driven Therapy and Immunotherapy in Screening Participants with Recurrent or Stage IV Non-Small Cell Lung Cancer (The Expanded Lung-MAP Screening Trial)
Cancer Type: Lung Cancer

Testing the Timing of Pembrolizumab Alone or With Chemotherapy as First Line Treatment and Maintenance in Non-small Cell Lung Cancer
Cancer Type: Lung Cancer

Targeted Therapy Directed by Genetic Testing in Treating Patients with Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Cancer Type: Lymphoma

Targeted Therapy Directed by Genetic Testing in Treating Patients with Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Cancer Type: Melanoma

A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies
Cancer Type: Melanoma

Targeted Therapy Directed by Genetic Testing in Treating Patients with Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Cancer Type: Multiple Myeloma

Tissue Collection and Natural History Study of Patients with Myelodysplastic Syndrome or Myeloproliferative Neoplasms
Cancer Type: Myelodysplastic Syndromes (MDS)

Targeted Therapy Directed by Genetic Testing in Treating Patients with Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Cancer Type: Ovarian Cancer

A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies
Cancer Type: Ovarian Cancer

Targeted Therapy Directed by Genetic Testing in Treating Patients with Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Cancer Type: Pancreatic Cancer

Targeted Therapy Directed by Genetic Testing in Treating Patients with Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Cancer Type: Plasma cell neoplasm

A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies
Cancer Type: Primary Peritoneal Cancer

Targeted Therapy Directed by Genetic Testing in Treating Patients with Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Cancer Type: Prostate Cancer

Targeted Therapy Directed by Genetic Testing in Treating Patients with Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Cancer Type: Skin Cancer (Non-Melanoma)

Targeted Therapy Directed by Genetic Testing in Treating Patients with Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Cancer Type: Stomach/ Gastric Cancer

A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies
Cancer Type: Stomach/ Gastric Cancer

Targeted Therapy Directed by Genetic Testing in Treating Patients with Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Cancer Type: Thyroid Cancer

Targeted Therapy Directed by Genetic Testing in Treating Patients with Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Cancer Type: Unknown Primary

Targeted Therapy Directed by Genetic Testing in Treating Patients with Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Cancer Type: Uterine Cancer


Northside Hospital Cancer Institute

1000 Johnson Ferry Road NE
Atlanta, GA 30342
404-303-3355 (p)
www.northside.com

driving directions

Clinical Trials
A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies
Cancer Type: Bile Duct Cancer

A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies
Cancer Type: Bladder Cancer

A Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib (LY2835219) in Participants With Prostate Cancer
Cancer Type: Bone Tumor

DSC-MRI in Measuring Relative Cerebral Blood Volume for Early Response to Bevacizumab in Patients with Recurrent Glioblastoma
Cancer Type: Brain & Spinal Cord Tumor

Observation or Radiation Therapy in Treating Patients with Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery
Cancer Type: Brain & Spinal Cord Tumor

Testing the Addition of a Blood Pressure Medication, Carvedilol, to HER-2 Targeted Therapy for Metastatic Breast Cancer to Prevent Cardiac Toxicity
Cancer Type: Breast Cancer

A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies
Cancer Type: Breast Cancer

Testing the Drug Atezolizumab or Placebo with Usual Therapy in First-Line HER2-Positive Metastatic Breast Cancer
Cancer Type: Breast Cancer

Tissue Collection and Natural History Study of Patients with Myelodysplastic Syndrome or Myeloproliferative Neoplasms
Cancer Type: Cancer-Related Syndrome

A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies
Cancer Type: Colon/Rectal Cancer

A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies
Cancer Type: Esophogeal Cancer

A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies
Cancer Type: Gynecologic Cancers

A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies
Cancer Type: Head and Neck Cancer

A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies
Cancer Type: Hematopoietic Malignancies

Tissue Collection and Natural History Study of Patients with Myelodysplastic Syndrome or Myeloproliferative Neoplasms
Cancer Type: Leukemia

A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies
Cancer Type: Liver Cancer / Hepatoblastoma

A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies
Cancer Type: Lung Cancer

Biomarker-Driven Therapy and Immunotherapy in Screening Participants with Recurrent or Stage IV Non-Small Cell Lung Cancer (The Expanded Lung-MAP Screening Trial)
Cancer Type: Lung Cancer

Testing the Timing of Pembrolizumab Alone or With Chemotherapy as First Line Treatment and Maintenance in Non-small Cell Lung Cancer
Cancer Type: Lung Cancer

A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies
Cancer Type: Melanoma

Tissue Collection and Natural History Study of Patients with Myelodysplastic Syndrome or Myeloproliferative Neoplasms
Cancer Type: Myelodysplastic Syndromes (MDS)

A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies
Cancer Type: Ovarian Cancer

A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies
Cancer Type: Primary Peritoneal Cancer

A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies
Cancer Type: Stomach/ Gastric Cancer


WellStar Cobb Hospital

3950 Austell Road
Austell, GA 30106
770-732-4000 (p)
www.wellstar.org

driving directions



WellStar Douglas Hospital

8954 Hospital Drive
Douglasville, GA 30134
770-949-1500 (p)
www.wellstar.org

driving directions



WellStar Kennestone Hospital

677 Church Street
Marietta, GA 30060
770-793-5000 (p)
www.wellstar.org

driving directions



WellStar Paulding Hospital

2518 Jimmy Lee Smith Parkway
Hiram, GA 30141
470-644-7000 (p)
www.wellstar.org

driving directions

**GeorgiaCancerInfo is not a medical practice. This is an informational web site provided by Georgia CORE, a nonprofit striving to provide current and comprehensive information on cancer care in Georgia through this website. If you find erroneous or missing information, please contact us.
Georgia CORE

 

Advancing Cancer Care through Partnerships and Innovation

Georgia CORE is a statewide nonprofit that leverages partnerships and innovation to attract more clinical trials, increase research, and promote education and early detection to improve cancer care for Georgians in rural, urban, and suburban communities across the state.